FORE8394
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for FORE8394, covering 2025-07-29 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations [Phase 2]